DuPont de Nemours (DD)
(Delayed Data from NYSE)
$86.59 USD
+2.26 (2.68%)
Updated Nov 7, 2024 04:00 PM ET
After-Market: $86.59 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
C Value C Growth B Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$86.59 USD
+2.26 (2.68%)
Updated Nov 7, 2024 04:00 PM ET
After-Market: $86.59 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
C Value C Growth B Momentum C VGM
Zacks News
Earnings Preview: Innospec (IOSP) Q1 Earnings Expected to Decline
by Zacks Equity Research
Innospec (IOSP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
DuPont de Nemours (DD) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
DuPont de Nemours (DD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Stepan Co. (SCL) Misses Q1 Earnings Estimates
by Zacks Equity Research
Stepan Co. (SCL) delivered earnings and revenue surprises of -24.47% and 0.26%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Is a Beat in the Offing for Linde (LIN) in Q1 Earnings?
by Zacks Equity Research
Higher industrial production in the March quarter is likely to have aided Linde's (LIN) Q1 earnings.
Will DuPont de Nemours (DD) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
DuPont de Nemours (DD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
DuPont (DD) Unveils Kevlar EXO Next-Generation Aramid Fiber
by Zacks Equity Research
DuPont (DD) Kevlar EXO offers never-before-seen ballistic and thermal performance while simultaneously providing a flexible and lightweight solution that enables users to operate at peak performance.
DuPont (DD) Launches New Silicone Blends for Topical Use
by Zacks Equity Research
Dupont (DD) develops new low-cyclic silicone blends in order to provide innovative solutions for a range of skin conditions and support its customers' good health and well-being.
DuPont (DD) Gains on Strong End-Market Demand and Innovation
by Zacks Equity Research
DuPont (DD) benefits from strength in water and industrial end-markets, innovation and pricing actions amid headwinds from higher input costs and sluggish demand in certain markets.
DuPont (DD) Up 31% in 6 Months: What's Behind the Rally?
by Zacks Equity Research
DuPont (DD) gains on strong demand in water and industrial end markets, investment in new product development and pricing actions.
Why You Should Retain DuPont (DD) Stock in Your Portfolio
by Zacks Equity Research
DuPont (DD) gains on healthy underlying demand in several end markets, focus on growth though innovation and pricing actions amid headwinds from sluggishness in some markets and input cost inflation.
Zacks Industry Outlook Highlights Air Products and Chemicals, DuPont de Nemours, Albemarle and Cabot
by Zacks Equity Research
Air Products and Chemicals, DuPont de Nemours, Albemarle and Cabot are part of the Zacks Industry Outlook article.
4 Diversified Chemical Stocks to Escape Industry Challenges
by Anindya Barman
Demand worries due to weakness in certain markets and raw material cost inflation pose headwinds for the Zacks Chemicals Diversified industry. APD, DD, ALB and CBT are poised to navigate the industry challenges.
Why Is DuPont de Nemours (DD) Down 6.2% Since Last Earnings Report?
by Zacks Equity Research
DuPont de Nemours (DD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
The Zacks Analyst Blog Highlights PepsiCo, Texas Instruments, HSBC, Petrobras and DuPont de Nemours
by Zacks Equity Research
PepsiCo, Texas Instruments, HSBC, Petrobras and DuPont de Nemours are included in this Analyst Blog.
Top Research Reports for PepsiCo, Texas Instruments & HSBC Holding
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including PepsiCo, Inc. (PEP), Texas Instruments Incorporated (TXN) and HSBC Holdings plc (HSBC).
What Makes DuPont de Nemours (DD) a New Buy Stock
by Zacks Equity Research
DuPont de Nemours (DD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Are Basic Materials Stocks Lagging ClevelandCliffs (CLF) This Year?
by Zacks Equity Research
Here is how Cleveland-Cliffs (CLF) and DuPont de Nemours (DD) have performed compared to their sector so far this year.
DuPont's (DD) Earnings and Revenues Surpass Estimates in Q4
by Zacks Equity Research
DuPont (DD) gains on disciplined pricing actions in Q4 amid headwinds from weak conditions in electronics and construction end markets.
DuPont de Nemours (DD) Reports Q4 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
The headline numbers for DuPont de Nemours (DD) give insight into how the company performed in the quarter ended December 2022, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
DuPont de Nemours (DD) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
DuPont de Nemours (DD) delivered earnings and revenue surprises of 12.66% and 0.67%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
DuPont (DD) Warms Up for Q4 Earnings: What's in the Cards?
by Zacks Equity Research
DuPont (DD) is likely to have benefited from strong end-market demand and its pricing and productivity actions in the fourth quarter.
Analysts Estimate Chemours (CC) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Chemours (CC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: DuPont de Nemours (DD) Q4 Earnings Expected to Decline
by Zacks Equity Research
DuPont de Nemours (DD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
DuPont (DD) Rides on Strong End-Market Demand and Innovation
by Zacks Equity Research
DuPont (DD) gains on strong demand in major end markets, portfolio and pricing actions and its focus on driving growth though innovation and new product launches.
DuPont (DD) Up 32% in 6 Months: What's Behind the Rally?
by Zacks Equity Research
DuPont (DD) gains on strong demand in semiconductor, water and industrial end-markets, investment in new product development and pricing actions.